ArticleBMJ open diabetes research & care2024

Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes.

Matteo Franchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.